Pharma & Biotech

Protagonist Therapeutics shares demonstrated renewed strength in Friday's trading session following the release of compelling long-term Phase 3 trial results...

Arcus Biosciences finds itself at the center of a sharp Wall Street divide. The biopharmaceutical company is receiving dramatically different...

Xeris Biopharma shares surged to unprecedented heights last week, establishing a new annual peak at $9.21 during Friday's trading session....

Pfizer has achieved significant regulatory milestones for its vaccine portfolio, with Singapore becoming the first Southeast Asian nation to approve...

Harmony Biosciences Holdings has delivered a stunning market surprise, propelling its equity value to remarkable heights. The biopharmaceutical firm's preliminary...

Soleno Therapeutics shares are approaching a pivotal moment with the upcoming quarterly results announcement scheduled for November 4. Following a...

Investors are closely watching Opko Health (OPK) as the company prepares to release its third-quarter 2025 financial results after market...

The fate of Anavex now rests with European drug regulators, creating a high-stakes scenario for investors. While the biotechnology firm...

The biotech sector has been challenging for many companies, but Ocugen stands out with a remarkable trading session. On Friday,...

The biotechnology software firm Simulations Plus finds itself navigating turbulent waters as legal pressures collide with a mixed financial performance....